Introduction to London HIV drug prescribing
NAT Response to London HIV drug prescribing
Moderated discussion on London HIV drug prescribing
BHIVA standards of care document: community input
Hepatitis C: where next?
HIV and brain function
HIV, antiretroviral therapy and the brain
Changes to HIV drug prescribing in London and what implications this could have for the rest of the UK
iPrEX Trial Design: statistical aspect of the results relating to the adherence data
Genital Tract – ART Implications for transmission
PIVOT Trial: Analyses of collected data
General Practice and HIV/AIDS
Accessing GP Care: the patient’s perspective
Outcomes in HIV
IAS Vienna 2010
CASCADE – Seroconverters Database
Vienna preview – a guide on what to look out for
Community meeting with Merk
BHIVA Feedback
What are observational studies
The UK Collaborative HIV Cohort Study
The UK HIV Drug Resistance Database
National Study of HIV in Pregnancy and Childhood
HPA Surveillance databases
New IT methods to protect data
How do we analyse observational databases
Issues for African sub-groups
Pre-Meeting for Gilead
Community meeting update from Gilead, Q & A
CROI Feedback
Confidence building workshop
Skill-building session
NHS structures in the UK
Getting other advocates involved
What next – active involvement
UKCHIC Proposed Ageing Study
Ageing with HIV: Project Overview Will we ever get to be old and wise?
BHIVA Conference overview
Pre-meeting for Abbott
Community Meeting update from Abbott
Community Q & A with Abbott
HIV and Ageing interactive session
BHIVA Routine Monitoring Guidelines
HIV Treatment Advocacy Overview
Definitions of Advocacy
Denver Principles
History of Advocacy Film highlights
Advocacy Training in Practice
Pre-Meeting for Bristol-Myers Squibb
Bristol-Myers Squibb Community Meeting, Q&A
Company meeting: BMS
IAS Conference Feedback